Actic Group AB is a Sweden-based company, which is primarily engaged in the provision of a range of recreational services. The Company operates a net of over 150 gym clubs located in Sweden, Norway, Finland, Germany and Austria. Actic Group AB provides personalized programs for individuals and groups, swimming lessons, access to swimming facilities and a number of pre-scheduled fitness activities, among others. The Company's operational model bases on one-time visits and subscriptions/club memberships, with an emphasis on serving small to mid-sized town inhabitants in cooperation with local municipalities. It also provides online booking services for memberships and classes via Internet portal.

L E Lundbergforetagen AB is an investment company that manages and develops a number of companies. The asset portfolio includes the wholly owned real estate company, Fastighets AB L E Lundberg, the publicly traded subsidiaries, Hufvudstaden and Holmen and the associated companies, Indutrade and Husqvarna. Co. also has major shareholdings in Industrivarden, Handelsbanken, Sandvik and Skanska. Co.'s subsidiary, L E Lundberg Kapitalforvaltning, is engages in securities trading. Operations consist of real estate operations, the manufacture and sale of printing paper, paperboard and sawn timber products, forest and power operations, and equity management (including securities trading).

Rezidor Hotel Group is an international hospitality company managing hotels, brands and assets owned by third parties. Co. operates two main brands, Radisson Blu and Park Inn by Radisson, as well as two more brands, Radisson Red and the Quorvus Collection targeting the luxury segment. All brands are developed and licensed by Co. in Europe, the Middle East and Africa under Master Franchise Agreements with Carlson, a privately held hospitality and travel company. As of Dec 31 2013, Co.'s existing portfolio consisted of 429 hotels with 94,800 rooms in operation and under development in 69 countries across Europe, the Middle East and Africa.

TechnipFMC is global leader in oil and gas projects, technologies, systems, and services. Co. offers subsea, surface, onshore, and offshore solutions for oil and gas projects. Co. serves customers worldwide. With Co.'s technologies and production systems, integrated expertise, and comprehensive solutions, Co. is transforming Co.'s clients' project economics. Co. is uniquely positioned to deliver greater efficiency across project lifecycles from concept to project delivery and beyond. Through innovative technologies and improved efficiencies, Co.'s offering unlocks new possibilities for Co.'s clients in developing their oil and gas resources.

Tomra Systems is a creator of sensor-based solutions for optimal resource productivity within the business streams of reverse vending, material recovery, compaction, recycling, mining, and food. Co.'s operating structure comprises two business areas and six business streams. The TOMRA Collection Solutions businesss area consists of three business streams: reverse vending, material recovery, as well as compaction. The TOMRA Sorting Solutions, business area consists of three business streams: food, recycling, and mining.

Ensco is an offshore contract drilling company engaged in providing offshore contract drilling services to the international oil and gas industry. As of Dec 31 2017, Co. owned and operated an offshore drilling rig fleet of 62 rigs. Co.'s rig fleet includes 12 drillships, 11 semisubmersible rigs, four moored semisubmersible rigs and 38 jackup rigs, including rigs under construction. Co.'s business consists of three operating segments: floaters, which includes its drillships and semisubmersible rigs; jackups; and other, which consists of management services on rigs owned by third-parties. Co.'s two reportable segments, floaters and jackups, provide one service, contract drilling.

Wilson Therapeutics AB is a Sweden-based biopharmaceutical company that is active in the development of a treatment for Wilson disease. Wilson disease is a genetic disease that causes copper poisoning. The Company's main product is Decuprate (tetrathiomolybdate), a de-coppering agent with a mechanism of action enabling it to bind copper to restore, in part or in whole, the body's own buffer system for copper in the liver. Decuprate also restores the natural excretion route via the bile rather than preventing copper to be absorbed or excreted through the kidneys. The Company operates through the Swedish subsidiaries Wilson Therapeutics Incentive AB and TTM Europe Development AB, as well as through Wilson Therapeutics Inc, a subsidiary based in the United States.